Please note that this webinar was presented in Mandarin.
Obtaining market approval for a new product can create several clinical challenges for medical device Sponsors. One way in which to tackle these challenges head-on is to develop effective biostatistics processes and plans early in the development process to navigate these complexities.
NAMSA invites you to listen as our expert Biostatisticians discuss strategies and best practices proven to help Sponsors efficiently meet clinical evidence needs and achieve market approval. Case studies will also be shared that detail insights obtained during each stage of development, how to select the most efficient study design and the best use of innovative statistical methods to mitigate risk and accelerate timelines.
Attendees of this webinar can expect to gain a better understanding of:
- Maximizing the value that Biostatisticians add by engaging them early for effective collaboration
- The unique insights Biostatisticians provide regarding complex study designs, from preclinical through post-market studies
- How NAMSA Biostatisticians draw upon diverse experiences and expertise using state-of-the-art methodology to achieve Client success